FDA Inspection 1219626 — CMC Pharmaceuticals, Inc.
The FDA completed an inspection of CMC Pharmaceuticals, Inc. on Sep 27, 2023 in Solon, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 27, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Solon, OH (United States)